Literature DB >> 34984710

Statistical considerations for cross-sectional HIV incidence estimation based on recency test.

Fei Gao1,2, Marlena Bannick3.   

Abstract

Longitudinal cohorts to determine the incidence of HIV infection are logistically challenging, so researchers have sought alternative strategies. Recency test methods use biomarker profiles of HIV-infected subjects in a cross-sectional sample to infer whether they are "recently" infected and to estimate incidence in the population. Two main estimators have been used in practice: one that assumes a recency test is perfectly specific, and another that allows for false-recent results. To date, these commonly used estimators have not been rigorously studied with respect to their assumptions and statistical properties. In this article, we present a theoretical framework with which to understand these estimators and interrogate their assumptions, and perform a simulation study and data analysis to assess the performance of these estimators under realistic HIV epidemiological dynamics. We find that the snapshot estimator and the adjusted estimator perform well when their corresponding assumptions hold. When assumptions on constant incidence and recency test characteristics fail to hold, the adjusted estimator is more robust than the snapshot estimator. We conclude with recommendations for the use of these estimators in practice and a discussion of future methodological developments to improve HIV incidence estimation via recency test.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  HIV; biomarker; incidence; prevalence; recency assay

Mesh:

Substances:

Year:  2022        PMID: 34984710      PMCID: PMC8918003          DOI: 10.1002/sim.9296

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  28 in total

1.  Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.

Authors:  Reshma Kassanjee; Christopher D Pilcher; Michael P Busch; Gary Murphy; Shelley N Facente; Sheila M Keating; Elaine Mckinney; Kara Marson; Matthew A Price; Jeffrey N Martin; Susan J Little; Frederick M Hecht; Esper G Kallas; Alex Welte
Journal:  AIDS       Date:  2016-09-24       Impact factor: 4.177

2.  Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests.

Authors:  R Brookmeyer; T C Quinn
Journal:  Am J Epidemiol       Date:  1995-01-15       Impact factor: 4.897

3.  Recent declines in HIV infections at Silom Community Clinic Bangkok, Thailand corresponding to HIV prevention scale up: An open cohort assessment 2005-2018.

Authors:  Sarika Pattanasin; Frits van Griensven; Philip A Mock; Wichuda Sukwicha; Santi Winaitham; Kesinee Satumay; Siobhan O'Connor; Andrew C Hickey; Taweesap Siraprapasiri; Joseph V Woodring; Pachara Sirivongrangson; Timothy H Holtz; Eileen F Dunne
Journal:  Int J Infect Dis       Date:  2020-07-11       Impact factor: 3.623

4.  Mixture models for calibrating the BED for HIV incidence testing.

Authors:  Severin Guy Mahiane; Agnès Fiamma; Bertran Auvert
Journal:  Stat Med       Date:  2014-05-10       Impact factor: 2.373

5.  Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection.

Authors:  Matthew M Cousins; Oliver Laeyendecker; Geetha Beauchamp; Ronald Brookmeyer; William I Towler; Sarah E Hudelson; Leila Khaki; Beryl Koblin; Margaret Chesney; Richard D Moore; Gabor D Kelen; Thomas Coates; Connie Celum; Susan P Buchbinder; George R Seage; Thomas C Quinn; Deborah Donnell; Susan H Eshleman
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

6.  Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.

Authors:  Yen T Duong; Reshma Kassanjee; Alex Welte; Meade Morgan; Anindya De; Trudy Dobbs; Erin Rottinghaus; John Nkengasong; Marcel E Curlin; Chonticha Kittinunvorakoon; Boonyos Raengsakulrach; Michael Martin; Kachit Choopanya; Suphak Vanichseni; Yan Jiang; Maofeng Qiu; Haiying Yu; Yan Hao; Neha Shah; Linh-Vi Le; Andrea A Kim; Tuan Anh Nguyen; William Ampofo; Bharat S Parekh
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

7.  Closer to 90-90-90. The cascade of care after 10 years of ART scale-up in rural Malawi: a population study.

Authors:  David Maman; Benson Chilima; Charles Masiku; Ahidjo Ayouba; Sophie Masson; Elisabeth Szumilin; Martine Peeters; Nathan Ford; Annette Heinzelmann; Benjamin Riche; Jean-François Etard
Journal:  J Int AIDS Soc       Date:  2016-02-15       Impact factor: 5.396

8.  A Comparison of South African National HIV Incidence Estimates: A Critical Appraisal of Different Methods.

Authors:  Thomas Rehle; Leigh Johnson; Timothy Hallett; Mary Mahy; Andrea Kim; Helen Odido; Dorina Onoya; Sean Jooste; Olive Shisana; Adrian Puren; Bharat Parekh; John Stover
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

9.  Trend of HIV/AIDS for the last 26 years and predicting achievement of the 90-90-90 HIV prevention targets by 2020 in Ethiopia: a time series analysis.

Authors:  Tadele Girum; Abebaw Wasie; Abdulsemed Worku
Journal:  BMC Infect Dis       Date:  2018-07-11       Impact factor: 3.090

10.  Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.

Authors:  Olubunmi R Negedu-Momoh; Oluseyi Balogun; Ibrahim Dafa; Akan Etuk; Edward Adekola Oladele; Oluwasanmi Adedokun; Ezekiel James; Satish R Pandey; Hadiza Khamofu; Titi Badru; Janet Robinson; Timothy D Mastro; Kwasi Torpey
Journal:  J Int AIDS Soc       Date:  2021-02       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.